News
Its generic name is Aripiprazole; its chemical structure is 7-[4-[4-(2,3-dichlorophenyl)-1piperazinyl]butoxy]-3,4-dihydrocarbostyril. This does not make Abilify a seeming candidate for popular ...
If you have schizophrenia, bipolar disorder, Tourette’s syndrome, or autism, aripiprazole (Abilify) can help you manage your symptoms. But it does have side effects. Here’s what you need to know.
In Italy, aripiprazole is available in 5mg, 10mg and 15mg dosage strengths. The manufacturer recommends an initial dosage of 10-15 mg/day and a target dosage of 15 mg/day. [] In clinical trials ...
The difference between the aripiprazole-augmented group and the switch-to-bupropion group reached statistical significance (difference 2.79 points, 95% CI 0.56-5.02, P=0.014, with a prespecified ...
Results from the pivotal trial 031-201-00181, that enrolled 266 patients, demonstrated that aripiprazole ready-to-use LAI 960 mg met the primary endpoint criteria establishing similarity of ...
Aripiprazole disrupts cellular synchrony in the suprachiasmatic nucleus and enhances entrainment to environmental light–dark cycles in mice. Frontiers in Neuroscience , 2023; 17 DOI: 10.3389 ...
Aripiprazole, which is recommended as an appropriate first-line atypical antipsychotic agent for the treatment of schizophrenia by a US Expert Consensus survey, [] provides clinicians with another ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results